Acumen Pharmaceuticals, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ABOS Nasdaq 2834 acumenpharm.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Acumen Pharmaceuticals, Inc.

VERAXA Biotech Shows Regulatory Progress on Cancer Therapy Platform - Jul 20th, 2026 10:15 am
Slate Medicines Appoints Mark W. Hahn to Board of Directors - Jul 16th, 2026 10:18 am
All You Need to Know About Acumen Pharmaceuticals (ABOS) Rating Upgrade to Buy - Jul 15th, 2026 10:00 am
Are Medical Stocks Lagging Acumen Pharmaceuticals (ABOS) This Year? - Jul 15th, 2026 7:40 am
Acumen Pharmaceuticals Highlights Enhanced Brain Delivery™ (EBD™) Program Data and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026 - Jul 15th, 2026 5:30 am
Acumen Pharmaceuticals and Unlearn Collaborate to Explore Analyses of Alzheimer's Disease Clinical Programs - Jul 9th, 2026 4:00 am
Acumen Pharmaceuticals to Present Data on Enhanced Brain Delivery™ (EBD™) Technology and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026 - Jul 7th, 2026 5:30 am
JCR Pharmaceuticals Announces That Acumen Pharmaceuticals Has Exercised its Exclusive Option to Develop Therapeutic Candidates for Alzheimer’s Disease, Enabled by J-Brain Cargo® Technology Platform - Jun 17th, 2026 10:30 am
Acumen Nominates 2 Therapies to Treat Alzheimer’s Disease - Jun 16th, 2026 4:18 pm
Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery™ (EBD™) Development Candidates for the Treatment of Alzheimer’s Disease - Jun 16th, 2026 5:30 am
Acumen Pharmaceuticals, Inc. Q1 2026 Earnings Call Summary - May 13th, 2026 6:30 am
Acumen Pharmaceuticals Inc (ABOS) Q1 2026 Earnings Call Highlights: Strategic Advances Amid ... - May 12th, 2026 1:01 pm
Acumen Pharmaceuticals Q1 Earnings Call Highlights - May 12th, 2026 7:07 am
Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights - May 12th, 2026 5:00 am
Acumen Pharmaceuticals to Participate in the Bank of America Securities 2026 Health Care Conference - May 7th, 2026 2:00 pm
Acumen Pharmaceuticals to Report First Quarter Financial Results on May 12, 2026 - May 5th, 2026 2:00 pm
Acumen Pharmaceuticals (ABOS) Loses 33.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Mar 31st, 2026 7:35 am
Is Acumen Pharmaceuticals (ABOS) Stock Outpacing Its Medical Peers This Year? - Mar 30th, 2026 7:40 am
Acumen Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary - Mar 27th, 2026 6:30 am
Acumen Pharmaceuticals Inc (ABOS) Q4 2025 Earnings Call Highlights: Strategic Advances Amid ... - Mar 26th, 2026 1:00 pm